Respiratory Syncytial Virus Infections
Showing 1 - 25 of >10,000
Respiratory Syncytial Virus Disease in Infants and Toddlers
Not yet recruiting
- Respiratory Syncytial Virus Infections
- (no location specified)
Jul 27, 2023
Respiratory Syncytial Virus Infections Trial in Saint Petersburg (RSV/Flu-01E low dose, RSV/Flu-01E high dose, Placebo)
Active, not recruiting
- Respiratory Syncytial Virus Infections
- RSV/Flu-01E low dose
- +2 more
-
Saint Petersburg, Russian FederationSmorodintsev Research Institute of Influenza
Jul 24, 2023
Respiratory Syncytial Virus Infections Trial (Placebo, Active)
Not yet recruiting
- Respiratory Syncytial Virus Infections
- Placebo
- Active
- (no location specified)
Oct 20, 2023
Respiratory Syncytial Virus Infection Trial (Sisunatovir, Placebo)
Not yet recruiting
- Respiratory Syncytial Virus Infection
- Sisunatovir
- Placebo
- (no location specified)
Oct 6, 2023
Respiratory Syncytial Virus Infections Trial in Adelaide (Recombinant Respiratory Syncytial Virus Vaccine (BARS13) /,
Active, not recruiting
- Respiratory Syncytial Virus Infections
- Recombinant Respiratory Syncytial Virus Vaccine (BARS13) /placebo
- +2 more
-
Herston, Queensland, Australia
- +1 more
Feb 1, 2023
RESCEU: Defining the Burden of RSV Disease
Active, not recruiting
- Respiratory Syncytial Virus Infections
- RSV Infection
- venepuncture
- nasopharyngeal swab
-
Oxford, Oxfordshire, United KingdomUniversity of Oxford
Oct 25, 2022
Health and Economic Burden of RSV Amongst Hospitalized Children
Recruiting
- Respiratory Syncytial Virus Infections
-
Amman, JordanJordan University Hospital
Dec 13, 2022
Respiratory Syncytial Virus Infections Trial in London (RV299, Placebo, Midazolam)
Completed
- Respiratory Syncytial Virus Infections
- RV299
- +2 more
-
London, Greater London, United KingdomRichmond Pharmacology Ltd
Sep 11, 2023
Respiratory Syncytial Virus Infections Trial (RSVPreF3 OA investigational vaccine, PCV20)
Not yet recruiting
- Respiratory Syncytial Virus Infections
- RSVPreF3 OA investigational vaccine
- PCV20
- (no location specified)
May 18, 2023
Respiratory Syncytial Virus Infections Trial in Cincinnati (PIV5-vectored RSV Vaccine (BLB-201) Low Dose, PIV5-vectored RSV
Not yet recruiting
- Respiratory Syncytial Virus Infections
- PIV5-vectored RSV Vaccine (BLB-201) Low Dose
- +2 more
-
Cincinnati, OhioCincinnati Children's Hospital Medical Center
Dec 20, 2022
Respiratory Syncytial Virus Infections Trial in Baltimore (200 mg RV521/78 µCi [ 14C]-RV521.)
Completed
- Respiratory Syncytial Virus Infections
- 200 mg RV521/78 µCi [ 14C]-RV521.
-
Baltimore, MarylandPharmaron Clinical Pharmacology Center
May 15, 2023
Respiratory Syncytial Virus Infections Trial (CodaVax-RSV, Normal Saline)
Not yet recruiting
- Respiratory Syncytial Virus Infections
- CodaVax-RSV
- Normal Saline
- (no location specified)
Nov 16, 2022
Respiratory Syncytial Virus Infections Trial (Nirsevimab)
Not yet recruiting
- Respiratory Syncytial Virus Infections
- (no location specified)
Jun 24, 2022
Respiratory Syncytial Virus Infections Trial in United States (AZM Group, Control Group)
Recruiting
- Respiratory Syncytial Virus Infections
- AZM Group
- Control Group
-
Birmingham, Alabama
- +4 more
Jun 16, 2022
Respiratory Syncytial Virus Infections Trial in Baltimore, Laurel (RSV ?NS2 ?1313 I1314L Vaccine, Placebo)
Recruiting
- Respiratory Syncytial Virus Infections
- RSV ΔNS2 Δ1313 I1314L Vaccine
- Placebo
-
Baltimore, Maryland
- +1 more
Dec 2, 2022
Respiratory Syncytial Virus Infection, Healthy Volunteers, Human Metapneumovirus Trial in Rolling Hills Estates, Miami,
Recruiting
- Respiratory Syncytial Virus Infection
- +2 more
- RSV/hMPV vaccine candidate Dose L
- +3 more
-
Rolling Hills Estates, California
- +2 more
Nov 14, 2023
Respiratory Syncytial Virus Infections Trial in Cincinnati, North Charleston (CPI-RSV-F Vaccine (BLB-201))
Completed
- Respiratory Syncytial Virus Infections
- CPI-RSV-F Vaccine (BLB-201)
-
Cincinnati, Ohio
- +1 more
Dec 5, 2022
Respiratory Syncytial Virus Infection Trial in Shanghai (Sisunatovir)
Not yet recruiting
- Respiratory Syncytial Virus Infection
-
Shanghai, Shanghai, ChinaHuashan Hospital
Aug 4, 2023
Respiratory Syncytial Virus Infections Trial in Hakata, Sumida, Kumamoto (VN-0200)
Recruiting
- Respiratory Syncytial Virus Infections
- VN-0200
-
Hakata, Fukuoka, Japan
- +2 more
Oct 27, 2022
Respiratory Syncytial Virus Infections Trial in Changsha (XW001, Placebo)
Completed
- Respiratory Syncytial Virus Infections
- XW001
- Placebo
-
Changsha, Hunan, ChinaThe Third Hospital of Changsha
Nov 30, 2022
COVID-19 Respiratory Infection, Influenza A, Influenza Type B Trial in Pasadena (Labcorp COVID-19+Flu+RSV Test Home Collection
Recruiting
- COVID-19 Respiratory Infection
- +3 more
- Labcorp COVID-19+Flu+RSV Test Home Collection Kit
-
Pasadena, CaliforniaExer Urgent Care
Aug 21, 2023
Respiratory Syncytial Virus Infections Trial in Baltimore (rRSV A/Maryland/001/11)
Suspended
- Respiratory Syncytial Virus Infections
- rRSV A/Maryland/001/11
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health
Feb 8, 2022
Infant RSV Infections and Health-related Quality of Life of
Recruiting
- RSV Infection
- +4 more
- cohort study
-
Munich, Bavaria, GermanyEFCNI
Oct 14, 2022
RSV Infection Trial in Chengdu (XW001, Placebo)
Recruiting
- RSV Infection
- XW001
- Placebo
-
Chengdu, Sichuan, ChinaWest China Second University Hospital, Sichuan University
Mar 20, 2023
Respiratory Syncytial Virus Infections, Influenza, Human Trial in London (RSV A Memphis 37, Influenza A/California/04/2009)
Terminated
- Respiratory Syncytial Virus Infections
- Influenza, Human
- RSV A Memphis 37
- Influenza A/California/04/2009
-
London, United KingdomNational Heart and Lung Institute, Imperial College London
Jun 23, 2022